0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Key Drivers Shaping the Spain Radiopharmaceuticals MarketThe Spain Radiopharmaceuticals Market growth continues to accelerate as radioembolisation with Yttrium-90 microspheres establishes itself as a standard treatment for primary and metastatic liver tumours. With hepatocellular carcinoma incidence rising in Spain linked to hepatitis C history and metabolic liver disease, and with colorectal cancer liver metastases representing a major oncological...0 Комментарии 0 Поделились 521 Просмотры 0 предпросмотр
-
Nuclear Medicine Radiopharmaceuticals Market Size, Share & Growth Analysis | 20.23% CAGR Through 2033The Nuclear Medicine Radiopharmaceuticals Market is covered by Business Market Insights with 2025 as the base year and 2026–2033 as the forecast period. The retrieved public source material for this batch did not expose all three headline values required for a verified numerical opening, so no market-size figure or CAGR is inferred. Management should view the market as a...0 Комментарии 0 Поделились 130 Просмотры 0 предпросмотр
-
Radiopharmaceuticals Market Outlook: Key Opportunities in Precision OncologyValued at USD 8.63 billion in 2025, the market is projected to reach USD 8.63 billion in 2026 and USD 20.94 billion by 2034, growing at a CAGR of 10.40% during the forecast period 2026–2034. The steady expansion of the global Radiopharmaceuticals Market is significantly propelled by the increasing prevalence of oncological and cardiovascular disorders globally, coupled with an aging...0 Комментарии 0 Поделились 295 Просмотры 0 предпросмотр
-
Rising Demand for Precision Oncology Fuels Radiopharmaceuticals Market GrowthIn an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Saudi Arabia and UAE Lead the GCC Radiopharmaceuticals MarketSaudi Arabia and the UAE are leading the GCC Radiopharmaceuticals Market, driven by ambitious healthcare transformation agendas, significant infrastructure investment, and growing cancer care capacity. Saudi Vision 2030 includes substantial investment in healthcare, including oncology centres and nuclear medicine facilities. The UAE's healthcare investment programmes and medical tourism...0 Комментарии 0 Поделились 355 Просмотры 0 предпросмотр
-
Why Radiopharmaceutical Innovation Is Accelerating Across Asia PacificThe Asia Pacific Radiopharmaceuticals Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Asia Pacific Radiopharmaceuticals Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive...0 Комментарии 0 Поделились 499 Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek